Report Categories
View AllRecent Articles
View All
White House Security Incident Secret Service Shoots Suspect Bystander Critically Injured Potential Market Impacts
Jim Cramer Endorses The TJX Companies TJX as a Strong Investment
Burberry Shares Rise on Moncler Takeover Speculation
Top Forecasters Project Inflation to Hit 6 in Q2 Survey Suggests
Tulsi Gabbard Resigns as Trumps Intelligence Chief to Care for Husband with Bone Cancer
CVU Q1 2021 Earnings EPS Surges Past Estimates But Stock Declines on Revenue Concerns
BioAge Labs Q1 2026 Earnings EPS Beat on Lower Loss PreRevenue Stage Continues
Farmland Partners Inc FPI Q1 2026 Earnings EPS Falls Short of Estimates Amid Lower Farm Income
NTAP Q1 2026 Earnings Slight EPS Beat Drives Positive Stock Reaction
PACB Q1 2026 Earnings Narrowerthanexpected loss drives positive market reaction
BridgeBio Pharma BBIO Slides 255 as Resistance Holds Near 693
QuantumScape QS Slides 215 as Stock Tests Key Support Levels
Silicom Ltd SILC Surges 6 Key Levels and Volume Insights
Jasper Therapeutics JSPR Edges Higher as Stock Tests Key Resistance Near 096
Soaring Fuel Costs Pressure US Trucking Sector as Geopolitical Risks Mount
Sterling Infrastructure Named IBD Stock Of The Day as Data Center Demand Drives Growth
Gold and Silver Prices Surge on USIran Peace Optimism Weaker Dollar
G7 Faces Fracture as Members Push to Scrap 2026 Communique
TBH Q4 2025 Earnings Massive EPS Miss Overshadowed by Stock Surge
CVLT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
RMR Q1 2026 Earnings EPS Misses Estimates but Stock Steadies
ORMP Q4 2025 Earnings Surprise Profit Beats Zero Estimate as Biotech Advances Pipeline
UMC Q1 2026 Earnings Massive EPS Beat Signals Strong Operational Leverage
MWA Q1 2026 Earnings EPS Beats Estimates by 647
External Links
Workday Surges on Upgraded Margin Outlook AI Adoption Cited by CEO
AbCellera Biologics ABCL Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher
PACK Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction
MAA Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency
Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status
VAL Q1 2026 Earnings EPS Misses Estimates as Offshore Drilling Headwinds Persist
Interlink Electronics Q3 2025 Earnings Narrowed Loss Beats Expectations Amid Opaque Revenue Picture
WEX Q1 2026 Earnings EPS Beats Estimates by 101 Shares Edge Higher
ROST Q1 2026 Earnings EPS Beats Estimates by 1466 Shares Surge
Abivax ABVX Q4 2025 Earnings WiderThanExpected Loss Highlights ClinicalStage Costs